Advanced Historical Income Statement

AMS Stock

209.00 3.50 1.65%

Historical analysis of Advanced Medical income statement accounts such as Interest Expense of 250.6 K, Total Revenue of 152.4 M or Gross Profit of 84.7 M can show how well Advanced Medical Solutions performed in making a profits. Evaluating Advanced Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Advanced Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Advanced Medical Sol latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Advanced Medical Sol is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Advanced Medical Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Advanced Income Statement Analysis

Advanced Medical Sol Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Advanced Medical shareholders. The income statement also shows Advanced investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Advanced Medical Income Statement Chart

At present, Advanced Medical's Total Revenue is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit is expected to grow to about 84.7 M, whereas Net Income From Continuing Ops is forecasted to decline to about 17.8 M.

Total Revenue Gross Profit Other Operating Expenses Research Development

Total Revenue

Total revenue comprises all receipts Advanced Medical Sol generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Advanced Medical Solutions minus its cost of goods sold. It is profit before Advanced Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Advanced Medical Sol. It is also known as Advanced Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Advanced Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Advanced Medical Sol current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Advanced Medical Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

	2022	2023	2024	2025 (projected)
Interest Expense	638K	384K	441.6K	250.6K
Depreciation And Amortization	8.8M	10.8M	12.4M	13.0M

Interest Expense Depreciation And Amortization

Advanced Medical income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Cost Of Revenue	Selling General Administrative	Selling And Marketing Expenses	Net Income From Continuing Ops	Tax Provision	Net Interest Income	Interest Income	Reconciled Depreciation
Depreciation And Amortization		0.36	0.9	0.85	0.94	0.51	0.58	0.95	0.8	0.92	0.61	0.65	0.55	0.73	0.96	0.94	0.89	0.44	0.54	0.69	0.87	0.92
Interest Expense	0.36		0.28	0.22	0.26	0.2	0.19	0.21	0.27	0.14	0.18	-0.36	0.2	0.1	0.35	0.28	0.32	0.03	-0.01	-0.23	-0.01	0.41
Total Revenue	0.9	0.28		0.99	0.98	0.81	0.86	0.88	0.97	0.94	0.88	0.58	0.84	0.91	0.98	0.97	0.98	0.68	0.66	0.62	0.76	0.75
Gross Profit	0.85	0.22	0.99		0.95	0.86	0.91	0.85	0.99	0.92	0.92	0.59	0.89	0.95	0.95	0.96	0.97	0.74	0.71	0.63	0.74	0.69
Other Operating Expenses	0.94	0.26	0.98	0.95		0.7	0.76	0.92	0.91	0.98	0.78	0.65	0.74	0.84	0.99	0.95	0.95	0.58	0.61	0.68	0.82	0.81
Operating Income	0.51	0.2	0.81	0.86	0.7		0.99	0.48	0.92	0.63	0.98	0.22	0.99	0.91	0.72	0.72	0.79	0.87	0.71	0.26	0.35	0.35
Ebit	0.58	0.19	0.86	0.91	0.76	0.99		0.57	0.95	0.7	1.0	0.32	1.0	0.94	0.77	0.78	0.85	0.88	0.75	0.37	0.45	0.41
Research Development	0.95	0.21	0.88	0.85	0.92	0.48	0.57		0.77	0.92	0.6	0.78	0.54	0.73	0.9	0.93	0.85	0.39	0.54	0.83	0.93	0.83
Ebitda	0.8	0.27	0.97	0.99	0.91	0.92	0.95	0.77		0.86	0.96	0.48	0.94	0.97	0.92	0.92	0.96	0.81	0.76	0.53	0.65	0.64
Total Operating Expenses	0.92	0.14	0.94	0.92	0.98	0.63	0.7	0.92	0.86		0.73	0.74	0.68	0.81	0.94	0.91	0.91	0.56	0.63	0.76	0.86	0.78
Income Before Tax	0.61	0.18	0.88	0.92	0.78	0.98	1.0	0.6	0.96	0.73		0.35	0.99	0.96	0.79	0.79	0.87	0.88	0.77	0.39	0.47	0.43
Total Other Income Expense Net	0.65	-0.36	0.58	0.59	0.65	0.22	0.32	0.78	0.48	0.74	0.35		0.27	0.54	0.57	0.65	0.54	0.29	0.51	0.97	0.92	0.58
Net Income	0.55	0.2	0.84	0.89	0.74	0.99	1.0	0.54	0.94	0.68	0.99	0.27		0.92	0.75	0.74	0.84	0.86	0.72	0.32	0.4	0.38
Income Tax Expense	0.73	0.1	0.91	0.95	0.84	0.91	0.94	0.73	0.97	0.81	0.96	0.54	0.92		0.85	0.88	0.9	0.88	0.84	0.57	0.65	0.57
Cost Of Revenue	0.96	0.35	0.98	0.95	0.99	0.72	0.77	0.9	0.92	0.94	0.79	0.57	0.75	0.85		0.97	0.97	0.59	0.6	0.61	0.78	0.83
Selling General Administrative	0.94	0.28	0.97	0.96	0.95	0.72	0.78	0.93	0.92	0.91	0.79	0.65	0.74	0.88	0.97		0.96	0.6	0.63	0.69	0.83	0.81
Selling And Marketing Expenses	0.89	0.32	0.98	0.97	0.95	0.79	0.85	0.85	0.96	0.91	0.87	0.54	0.84	0.9	0.97	0.96		0.67	0.62	0.58	0.73	0.75
Net Income From Continuing Ops	0.44	0.03	0.68	0.74	0.58	0.87	0.88	0.39	0.81	0.56	0.88	0.29	0.86	0.88	0.59	0.6	0.67		0.9	0.33	0.38	0.32
Tax Provision	0.54	-0.01	0.66	0.71	0.61	0.71	0.75	0.54	0.76	0.63	0.77	0.51	0.72	0.84	0.6	0.63	0.62	0.9		0.57	0.59	0.49
Net Interest Income	0.69	-0.23	0.62	0.63	0.68	0.26	0.37	0.83	0.53	0.76	0.39	0.97	0.32	0.57	0.61	0.69	0.58	0.33	0.57		0.95	0.6
Interest Income	0.87	-0.01	0.76	0.74	0.82	0.35	0.45	0.93	0.65	0.86	0.47	0.92	0.4	0.65	0.78	0.83	0.73	0.38	0.59	0.95		0.79
Reconciled Depreciation	0.92	0.41	0.75	0.69	0.81	0.35	0.41	0.83	0.64	0.78	0.43	0.58	0.38	0.57	0.83	0.81	0.75	0.32	0.49	0.6	0.79

Click cells to compare fundamentals

Advanced Medical Account Relationship Matchups

Advanced Medical income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	6.8M	8.8M	8.8M	10.8M	12.4M	13.0M
Interest Expense	861K	1.1M	638K	384K	441.6K	250.6K
Total Revenue	86.8M	108.6M	124.3M	126.2M	145.1M	152.4M
Gross Profit	42.7M	56.1M	68.6M	70.1M	80.7M	84.7M
Other Operating Expenses	75.1M	88.0M	98.2M	107.3M	123.4M	129.6M
Operating Income	11.7M	20.6M	26.1M	18.9M	21.7M	22.8M
Ebit	10.7M	20.6M	26.1M	20.6M	23.7M	24.9M
Research Development	3.7M	3.8M	4.3M	6.6M	7.6M	8.0M
Ebitda	17.5M	29.4M	34.9M	31.4M	36.1M	37.9M
Total Operating Expenses	31.0M	35.5M	42.5M	51.3M	58.9M	61.9M
Income Before Tax	9.8M	21.6M	25.4M	21.2M	24.3M	25.5M
Total Other Income Expense Net	(641K)	(1.4M)	542K	2.3M	2.0M	2.1M
Net Income	8.6M	17.5M	20.4M	15.9M	18.3M	19.2M
Income Tax Expense	1.3M	4.1M	5.0M	5.3M	6.1M	6.4M
Cost Of Revenue	44.1M	52.5M	55.7M	56.1M	64.5M	67.7M
Selling General Administrative	33.7M	37.0M	47.4M	50.7M	58.3M	61.2M
Selling And Marketing Expenses	1.1M	1.5M	1.6M	1.5M	1.7M	1.8M
Net Income From Continuing Ops	8.6M	17.5M	20.4M	15.9M	18.3M	17.8M
Tax Provision	1.5M	4.5M	5.5M	5.3M	6.1M	5.0M
Net Interest Income	(641K)	(1.0M)	1.0M	2.1M	2.4M	2.5M
Interest Income	220K	84K	1.7M	2.5M	2.8M	3.0M
Reconciled Depreciation	6.8M	8.8M	8.8M	10.8M	12.4M	7.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

EBR	Centrais Electricas Brasileiras
HE	Hawaiian Electric Industries
VFC	VF Corporation

Other Information on Investing in Advanced Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Advanced Historical Income Statement

About Advanced Income Statement Analysis

Advanced Medical Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Advanced Medical income statement Correlations

Advanced Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Advanced Medical income statement Accounts

Also Currently Popular

Other Information on Investing in Advanced Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Income Before Tax	+ 1.0	Ebit
Net Income	+ 1.0	Ebit
Gross Profit	+ 0.99	Total Revenue
Ebitda	+ 0.99	Gross Profit
Cost Of Revenue	+ 0.99	Other Operating Expenses
Ebit	+ 0.99	Operating Income

Total Other Income Expense Net	- 0.36	Interest Expense
Net Interest Income	- 0.23	Interest Expense
Interest Income	- 0.01	Interest Expense
Tax Provision	- 0.01	Interest Expense